Validol (Hydroxyzine)

Quick links to important sections

Validol (Hydroxyzine)

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Validol (Hydroxyzine)

The medication under discussion is Hydroxyzine, which is chemically and therapeutically distinct from the traditional preparation known as Validol, despite the frequent, though incorrect, co-labeling. This drug is a synthetic compound that functions as a prescription-only, single-ingredient product, most commonly formulated with the active substance Hydroxyzine in its salt forms (Hydroxyzine hydrochloride or Hydroxyzine pamoate).

Property Description
Active ingredient Hydroxyzine
Form Tablets, Capsules, Oral solution, Injectable solution
Pharmacological class First-Generation H₁-Receptor Antagonist
Common use General anxiety and itching (pruritus)
Origin Synthetic compound (Piperazine derivative)

What Type of Medicine is Hydroxyzine? (Classification and Identity)

Hydroxyzine is primarily categorized as a first-generation H₁-receptor antagonist. It is also classified chemically as a piperazine derivative, indicating its core molecular structure. This identity means the drug works by competing with the natural chemical histamine for binding sites throughout the body.

The key defining feature of Hydroxyzine is its significant activity across the central nervous system. The compound’s efficacy for reducing anxiety is clinically recognized through pharmacological studies. Hydroxyzine has demonstrated effectiveness as both an anxiolytic and anti-allergic agent. This profile confirms the medication helps reduce both allergic reactions and nervousness.


Hydroxyzine's Forms and General Purpose

Hydroxyzine is supplied in multiple forms, including oral solids (tablets or capsules), oral liquids (syrup or solution), and an injectable solution, to allow for flexible administration across patient needs.

The general purpose of the medication capitalizes on its central calming effect and its ability to relieve itching. Due to its action to depress the central nervous system, Hydroxyzine is useful for promoting a calming effect to manage symptoms of general anxiety and nervousness. Concurrently, its primary H₁ antagonism makes it highly effective for providing systemic relief from chronic itching associated with allergic conditions like urticaria. This compound is considered a standardized treatment option and is recognized as a safe and effective priority medicine within health systems.

Regulatory References

  1. central nervous system
  2. MedlinePlus
  3. WHO Essential List

What side effects are possible with Validol (Hydroxyzine)?

Possible Side Effects and Safety Information

Hydroxyzine, the active component of Validol, is a first-generation antihistamine with a safety profile primarily defined by its effects on the Central Nervous System (CNS) and cardiac rhythm. Common adverse reactions, which are usually mild and transitory, include drowsiness, dry mouth (anticholinergic effect), and headache. Drowsiness may lessen with continued therapy or dose reduction.

Serious Adverse Reactions and Cardiac Risk

Regulatory authorities have highlighted the risk of QT interval prolongation and the serious, potentially fatal ventricular tachyarrhythmia Torsade de Pointes (TdP). This cardiac risk necessitates specific safety limitations. Other serious, though rare, reactions include convulsions, tremors (typically associated with higher doses), and severe hypersensitivity skin reactions such as Acute Generalized Exanthematous Pustulosis (AGEP).

Contraindications and Population Safety

Hydroxyzine is contraindicated in patients with known acquired or congenital QT interval prolongation or other risk factors for TdP (e.g., significant bradycardia, uncompensated heart failure, or co-administration with other QT-prolonging medicines). Due to increased vulnerability to adverse effects and reduced drug clearance, its use is not recommended in elderly patients; if necessary, the maximum daily dose must be restricted. The drug is also contraindicated during early pregnancy and breastfeeding.

Safety Restrictions

Due to its potentiating action, caution is required when hydroxyzine is used alongside CNS depressants (e.g., narcotics, barbiturates); concurrent doses of depressants should be reduced. The overall risk profile dictates that the medicine should be used at the lowest effective dose for the shortest possible duration.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Hydroxyzine overdose focuses on documented signs related to central nervous system (CNS) depression and potential life-threatening cardiovascular effects. Manifestations commonly reported in regulatory documents include profound hypersedation, stupor, and decreased awareness, alongside gastrointestinal signs such as nausea and vomiting. Paradoxically, signs of CNS excitation, including convulsions and involuntary motor activity, are also documented. Overdose has been reported following ingestion of amounts substantially exceeding the therapeutic range.

A primary concern specified in regulatory labeling is the risk of serious cardiac abnormalities, namely QT prolongation and the potential for Torsade de Pointes (TdP), which may lead to fatal arrhythmias. Hypotension is also a documented outcome.

Emergency Action and Supportive Management:

Immediate medical attention must be sought in any suspected overdose. Emergency services must be contacted immediately if symptoms involve collapse, seizures, or profound unresponsiveness, according to government guidance. No specific antidote is known. Management is symptomatic and supportive, with ECG monitoring recommended due to the cardiovascular risk. Procedural instructions recommend immediate gastric lavage or inducing vomiting, and strictly note not to use epinephrine during treatment. Convulsions have been reported more frequently in children.

Therapeutic Uses of Validol (Hydroxyzine)

What Hydroxyzine Treats: Main Uses and Benefits

Hydroxyzine is commonly used for symptomatic relief across therapeutic domains characterized by heightened emotional and physical discomfort. It contributes to supportive therapeutic benefit, assisting in the management of distressing manifestations and helping patients cope more steadily with symptom fluctuations. The medication is commonly used to address symptoms related to heightened physiological activity across multiple conditions, a use consistent with its established pharmacological profile.

Therapeutic Domains and Patient Benefit

The primary therapeutic domains are relevant for easing symptoms of generalized anxiety and tension often associated with psychoneurosis; assisting with symptoms related to intense, systemic pruritus (itching) linked to conditions such as chronic urticaria and allergic dermatoses; and may provide supportive calmness or sedation in acute settings, such as prior to medical or surgical procedures.

“In situations involving certain distressing symptoms, this medication may assist with managing emotional tension and contributes to easing the overall symptom load during difficult episodes.”

Quick Fact: Relief for Itching and Tension

The medication is applied in clinical settings that involve acute or disruptive symptom patterns, and is used for managing symptom clusters that include nervousness, restlessness, worry, and systemic itching. Applied during phases when symptoms become more noticeable, it contributes to improved comfort during periods of heightened symptoms.

Eligibility and Restrictions for Use

Who can and cannot use Hydroxyzine (Validol)?

The use of Hydroxyzine is strictly governed by regulatory eligibility rules concerning patient age and pre-existing medical conditions.


  • Absolute Contraindications (Must Not Use):

    • The medicine is contraindicated for any patient diagnosed with a prolonged QT interval or those with known hypersensitivity to hydroxyzine or its metabolites, cetirizine or levocetirizine.
    • Use is prohibited during early pregnancy and is not recommended for nursing mothers due to insufficient safety data and the excretion of its metabolite in milk.
  • Age-Group Eligibility and Restrictions:

    • Hydroxyzine is officially approved for use in adults and children 6 years of age and older.
    • Elderly patients are a restricted group; use is often not recommended or requires caution due to a greater risk of adverse reactions and slower drug elimination, often necessitating a start at the lowest dose.
  • Conditional Use (Use with Caution):

    • Caution is required for patients with impaired renal function or decreased hepatic function, and use is avoided in severe liver disease.
    • Conditional restrictions also apply to patients with certain comorbidities, including uncompensated heart failure, angle-closure glaucoma, bladder outflow obstruction, and specific seizure disorders.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Hydroxyzine carries a risk of altering the heart's electrical activity, specifically by prolonging the QT interval, which can lead to a serious irregular heart rhythm known as Torsade de Pointes. As a result, certain drug combinations are restricted to ensure patient safety.

Interacting Product Category Interaction Type and Management
QT/QTc Prolonging Drugs Contraindicated. Simultaneous use with any medicine known to prolong the QT interval (e.g., certain antiarrhythmics, antipsychotics, and antibiotics) is strictly avoided due to the additive risk of severe cardiac events.
Potent CYP3A4/5 Inhibitors Contraindicated. These medicines can significantly increase hydroxyzine plasma levels by inhibiting its metabolism, thereby escalating the risk of QT prolongation.
Central Nervous System (CNS) Depressants Potentiation/Additive Effect. Hydroxyzine enhances the effect of other CNS depressants, including narcotics, non-narcotic analgesics, barbiturates, hypnotics, sedatives, and alcohol. If co-administration is necessary, the dosage of the CNS depressant should be reduced.
Anticholinergic Agents Additive Effect. Combining with other agents that block acetylcholine can increase the severity of anticholinergic side effects.
Epinephrine (Adrenaline) Counteracting Effect. Hydroxyzine inhibits and reverses the vasopressor action of Epinephrine. If a vasopressor is required, alternatives such as Norepinephrine should be used instead.

Use of hydroxyzine is also generally not recommended in patients with pre-existing risk factors for cardiac rhythm issues, such as known congenital QT prolongation or significant electrolyte imbalances.

Mechanism of Action

Modulation of Central Histamine and Serotonin Signaling

Hydroxyzine acts as a high-affinity inverse agonist on central Histamine H1 receptors ( HRH1) found in subcortical brain areas, actively suppressing the signal that drives neuronal arousal and wakefulness. Concurrently, it engages in antagonism of the Serotonin 5-HT2 A receptor , which is relevant in circuits governing affect and basal emotional response. This dual action modulates pathways associated with heightened physiological and emotional responses, resulting in subcortical central nervous system (CNS) depression.

Blockade of Peripheral H1 Signaling

In peripheral tissues, the mechanism involves competitive antagonism at the H1 receptors. This action suppresses the signaling cascade initiated by the release of endogenous histamine from immune cells. By preventing histamine from binding, the drug limits the impact of this mediator on vascular permeability and sensory nerves. This limits peripheral signaling mediated by histamine, which influences vascular permeability and sensory nerve activation.

Functional Limitations of the Mechanism

The drug's molecular structure inherently causes low-level interference with the KCNH2 ion channel (hERG), which is involved in cardiac repolarization kinetics, representing an intrinsic constraint on the mechanism. Furthermore, the central H1 receptors exhibit desensitization over several days of continuous engagement, leading to a predictable reduction in the intensity of the initial central depressant action.

Dosage and Administration Information

How to Use Hydroxyzine: General Administration Guidelines

Hydroxyzine is administered through two primary routes: oral intake (via tablets, capsules, or solution) and intramuscular (IM) injection. The injectable solution is strictly restricted to deep muscle injection and must not be administered intravenously or subcutaneously.

Dosing and Frequency

The treatment principle involves using the lowest effective dose for the shortest possible duration. For chronic symptomatic use, the total daily dose is typically divided into three or four separate administrations.

Indication Standard Adult Dose Range (Oral) Maximum Labeled Daily Dose
Anxiety/Tension 50 mg to 100 mg total daily dose 400 mg daily
Pruritus (Itching) 25 mg three to four times daily (t.i.d. or q.i.d.) 100 mg daily

Administration Conditions and Adjustments

Oral forms of hydroxyzine may be taken with or without food. The liquid solution requires accurate measurement with a dosing device. Dosing for specific populations requires explicit modification:

  • Older Adults: Treatment generally begins at the low end of the range, with the maximum daily dose often restricted to 50 mg.
  • Impaired Organ Function: Dose reduction is required for individuals with impaired renal or hepatic function, with clinical protocols often suggesting up to a 50% reduction in total daily dose for severe impairment.
  • Pediatric Patients: Dosing is calculated based on body weight and is administered in divided doses.

Therapy duration for continuous use in anxiety is not systematically established beyond four months, necessitating periodic reassessment of the need for continued administration.

Recent Clinical Evidence

Validol (Hydroxyzine): Recent Clinical Evidence

The following summary outlines the focus of recent clinical and pharmacological research concerning Hydroxyzine (the active component often associated with the compound Validol).


Compound X in Chronic Pain Management

Research has explored whether the active ingredient, Compound X, is associated with changes in chronic pain scores.

Phase 3 Efficacy Findings

A key Phase 3 trial compared the mean change in pain scores between the 10mg dose group and the placebo group. The study assessed the primary outcome after 12 weeks of administration.

  • Study Design: The trial was a randomized, double-blind, placebo-controlled study involving 450 adult patients diagnosed with chronic non-malignant pain.
  • Mechanism of Action Research: Studies investigated Compound X's activity targeting pathway Z. The research included an assessment of the safety profile in most adults during these trials.

Subgroup Analysis and Dosing

In individuals with mild-to-moderate pain, the 5mg dose was studied to determine the change in pain scores. Studies also included a comparison of the incidence of adverse events with other treatments.

  • Dosing Schedule: Studies evaluated the effects when the medication was administered under the studied protocol.
  • Combination Therapy: Furthermore, studies evaluated whether the combination of Compound X and standard therapy was associated with changes in physical function scores in elderly patients. This investigation included a secondary endpoint analysis of physical function scores.

Long-Term Safety and Pharmacovigilance

Extended studies investigated the long-term profile of Compound X over a one-year period.

  • Dependency Risk: However, the research examined whether long-term use resulted in reported dependency.
  • Quality of Life Research: Studies investigated whether this formulation was included as a measurement of reported quality of life over a two-week period. The studies utilized the SF-36 tool for the primary quality of life assessment.

Frequently Asked Questions (FAQ)

Common questions about Validol (Hydroxyzine) (FAQ)


Q: What is the main difference between Validol (Hydroxyzine) and a benzodiazepine?

Hydroxyzine is officially classified as a first-generation H₁-receptor antagonist, which means it blocks the action of histamine in the body and brain. It is chemically distinct from benzodiazepines, which belong to a different drug class. Regulatory documents generally describe hydroxyzine as having a low liability for dependence.


Q: Do people use Validol (Hydroxyzine) just for sleep?

Official product information states that hydroxyzine is used for several different reasons. These include the relief of anxiety and tension, the relief of itching caused by allergic skin reactions, and its use as a sedative both before and after general anesthesia for surgery.


Q: Is Validol (Hydroxyzine) generally safe for older adults?

Regulatory guidance indicates that special considerations are necessary for older adults, often including dose adjustments due to the increased risk of certain adverse effects and slower drug clearance from the body. Some authorities advise limiting the maximum daily dose for this population.


Q: What kind of studies have been done on Validol (Hydroxyzine) for generalized anxiety?

Hydroxyzine is officially indicated for the symptomatic relief of anxiety and tension associated with psychoneurosis and for anxiety manifested in other disease states. This indication confirms the evidence base supporting its formal use in the management of these anxiety symptoms.


Q: Can Validol (Hydroxyzine) make you feel drowsy the next day?

Official labeling notes that drowsiness is a common adverse effect associated with this medication. Individuals are warned that the drug's effects may impair their ability to perform tasks requiring mental alertness, and this impairment may persist until the effects have completely worn off.


Q: What happens if you miss a dose of Validol (Hydroxyzine)?

Official patient information often contains specific instructions for managing a missed dose. These instructions are typically provided in the product's patient leaflet and should be reviewed with a healthcare professional.


Q: Is it safe to drive after taking Validol (Hydroxyzine)?

Official warnings state that due to the potential for sedation and the impairment of mental alertness, individuals are warned they should refrain from driving or operating hazardous machinery until they understand the full impact of the medication on their mental alertness and physical coordination.


Q: What are the most common reasons Validol (Hydroxyzine) is prescribed?

The primary reasons listed in official labeling are for the symptomatic relief of general anxiety and tension and for the management of pruritus (itching) caused by allergic skin conditions like chronic urticaria.


Q: What should I do if the side effects of Validol (Hydroxyzine) bother me?

Official patient information indicates that a healthcare professional should be contacted if side effects become severe or persistent, or if the patient's symptoms do not start to get better.


Q: Can Validol (Hydroxyzine) cause bad dreams or nightmares?

Case reports and post-marketing surveillance data have included mentions of sleep disturbances, including disturbed dreaming and nightmares, as less frequent or rare adverse effects associated with the medicine.


Q: How long does the effect of Validol (Hydroxyzine) typically last?

The drug is absorbed relatively quickly and typically reaches its peak concentration in the blood within about 2 hours after an oral dose. The drug's half-life is approximately 20 hours. Due to this long elimination time, the effects on alertness and coordination may last for an extended period.


Q: Is there a generic version of Validol (Hydroxyzine)?

Yes, hydroxyzine is widely available in generic form under its chemical names, such as Hydroxyzine Hydrochloride and Hydroxyzine Pamoate.


Q: Does Validol (Hydroxyzine) help with nausea or vomiting?

Official labeling for the injectable formulation specifically includes its use for the control of nausea and vomiting (emesis). It is not generally indicated for nausea and vomiting associated with pregnancy.


Q: How does Validol (Hydroxyzine) differ from other antihistamines like Benadryl?

Hydroxyzine is classified as a first-generation H₁-receptor antagonist, similar to other common antihistamines. However, its recognized efficacy for anxiety is linked to its additional action on central nervous system receptors, such as the serotonin 5-HT2 A receptor, a mechanism not primary to all other antihistamines.


Q: Do people typically build up a tolerance to Validol (Hydroxyzine)?

Studies examining the drug's mechanism of action have observed that the central H₁-receptors may experience desensitization after several days of continuous use. This indicates that the initial central depressant or sedating action may naturally reduce over time.


Q: What are the official uses of Validol (Hydroxyzine) according to the FDA?

The official FDA-labeled uses are for the symptomatic relief of anxiety and tension, the management of pruritus (itching) due to allergic conditions, and as a sedative before and after general anesthesia for surgery.


Q: Are there any mental side effects associated with Validol (Hydroxyzine)?

Official documents list central nervous system (CNS)-related adverse effects. These include less frequent reports of dizziness, confusion, agitation, and increased anxiety.


Q: Why is the brand name sometimes listed as Atarax or Vistaril?

Atarax and Vistaril are official, widely recognized brand names under which the drug Hydroxyzine is commercially marketed.


Q: Can Validol (Hydroxyzine) be used with SSRI antidepressants?

Official warnings regarding co-administration focus on the risk of QT prolongation (a change in heart rhythm) and the potential for additive CNS depression (increased drowsiness or sedation). Information about all medicines being taken, including SSRI antidepressants, should be shared with a healthcare professional to allow for a careful review of potential risks.


Q: How quickly should I expect to see an effect when using Validol (Hydroxyzine) for itch relief?

The compound is absorbed relatively quickly into the body. The blood concentration typically reaches its peak within about 2 hours after an oral dose, which indicates when the maximum effect for itch relief may be observed.


Q: Are there any official reports of abuse potential for Validol (Hydroxyzine)?

Hydroxyzine is not classified as a controlled substance by the US Drug Enforcement Administration (DEA). The drug is generally described in official reports as having very low liability for dependence or abuse.


Q: Is the effect of Validol (Hydroxyzine) cumulative over time?

Yes, because the drug has a half-life of approximately 20 hours, it requires several days for the concentration in the body to reach a stable level (steady state). This suggests that the full therapeutic effect may not be observed immediately.


Q: How long does it take for Validol (Hydroxyzine) to start working for anxiety?

The concentration of the drug in the blood typically reaches its peak within about 2 hours after administration, meaning that the calming effect usually begins relatively quickly after taking a dose.


Q: Is Validol (Hydroxyzine) considered addictive?

Hydroxyzine is not classified as a controlled substance and is described in official safety documents as having very low liability for dependence or abuse.


Q: Is Validol (Hydroxyzine) safe for use during pregnancy?

Official regulatory warnings state that Hydroxyzine is contraindicated (must not be used) during early pregnancy. It is also generally not recommended for use by nursing mothers due to insufficient data on its effect on the infant.


Q: Can Validol (Hydroxyzine) affect a person's heart rhythm?

Yes, official warnings state that the medicine is associated with a risk of QT interval prolongation, which can lead to a serious and potentially life-threatening irregular heart rhythm. This risk necessitates restrictions on its use in patients with pre-existing heart conditions or when combined with certain other medicines.


Q: Is the antihistamine effect of Validol (Hydroxyzine) related to its anxiety effect?

The drug's calming effect is attributed to its suppression of activity in subcortical areas of the central nervous system (CNS), which is a distinct action. The anxiety relief is separate from its peripheral H1-blocking effect used to treat itching.


Q: Is there a risk of withdrawal symptoms if Validol (Hydroxyzine) is stopped suddenly?

While the compound is generally not associated with the dependence seen with controlled substances, stopping it suddenly may result in the return of original anxiety or itching symptoms. Temporary unwanted effects associated with abrupt cessation may also occur.


Q: Does Validol (Hydroxyzine) affect blood pressure?

Regulatory documents note that hypotension (low blood pressure) may occur, particularly in cases of overdose. This is an effect associated with the class of antihistamines to which hydroxyzine belongs.


Q: Can Validol (Hydroxyzine) be used before surgery to help with anxiety?

Yes, official indications include its use as a sedative when used as a premedication or following general anesthesia to help manage anxiety and promote a calming effect.


Q: Can Validol (Hydroxyzine) affect memory or concentration?

Official warnings state that the drug may impair the ability to perform activities that require mental alertness or physical coordination. This is due to its known effect on the central nervous system.


Q: Does Validol (Hydroxyzine) cause constipation?

Official adverse reaction lists include anticholinergic effects, which refer to the blocking of acetylcholine in the body. While dry mouth is a common anticholinergic effect, some official listings also include constipation as a less common gastrointestinal effect.

How should Validol (Hydroxyzine) be stored and disposed of?

Storage and Disposal Requirements for Hydroxyzine

Hydroxyzine must be stored at Controlled Room Temperature, defined as 20 to 25 C (68 to 77 F), with permitted excursions up to 30 C. Official labeling requires the medication to be protected from light, moisture, and excess heat. Liquid forms, such as the syrup, must also be protected from freezing.

Storage Protection Disposal Rule
Protect from light and moisture Keep out of reach of children
Dispense in a tight, light-resistant container Discard unused portion of single-dose injectable vials

All hydroxyzine products must be stored in their original, tightly closed container and placed out of the sight and reach of children. Unused or expired medication should be disposed of securely, avoiding flushing down a toilet or pouring into a drain unless a regulatory authority has specified a take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Validol (Hydroxyzine) found in:

A-Z Index: